Evidence map›Paper›PMID 13680309›Full record

ArticleJournal of molecular modeling2003

Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design I: discovery of anticancer compounds.

Humberto Gonzáles-Díaz, Ornella Gia, Eugenio Uriarte, Ivan Hernádez, Ronal Ramos, Mayrelis Chaviano, Santiago Seijo, Juan A Castillo, Lázaro Morales, Lourdes Santana and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A survey of quantitative descriptions of molecular structure.Current topics in medicinal chemistry · 2012
    Article
  7. Review
  8. Article
  9. Databases and QSAR for cancer research.Cancer informatics · 2007
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Humberto Gonzáles-DíazChemical Bioactives Center, Central University of Las Villas, 54830 Santa Clara, Villa Clara, Cuba. humbertogd@vodafone.es
Ornella Gia
Eugenio Uriarte
Ivan Hernádez
Ronal Ramos
Mayrelis Chaviano
Santiago Seijo
Juan A Castillo
Lázaro Morales
Lourdes Santana
Delali Akpaloo
Enrique Molina
Maikel Cruz
Luis A Torres
Miguel A Cabrera
Universidad Central "Marta Abreu" de las Villas (UCLV) · CUUniversidade de Santiago de Compostela · ESUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A simple stochastic approach, designed to model the movement of electrons throughout chemical bonds, is introduced. This model makes use of a Markov matrix to codify useful structural information in QSAR. The self-return probabilities of this matrix throughout time ((SR)pi(k)) are then used as molecular descriptors. Firstly, a calculation of (SR)pi(k) is made for a large series of anticancer and non-anticancer chemicals. Then, k-Means Cluster Analysis allows us to split the data series into clusters and ensure a representative design of training and predicting series. Next, we develop a classification function through Linear Discriminant Analysis (LDA). This QSAR discriminates between anticancer compounds and non-active compounds with a correct global classification of 90.5% in the training series. The model also correctly classified 86.07% of the compounds in the predicting series. This classification function is then used to perform a virtual screening of a combinatorial library of coumarins. In this connection, the biological assay of some furocoumarins, selected by virtual screening using the present model, gives good results. In particular, a tetracyclic derivative of 5-methoxypsoralen (5-MOP) has an IC50 against HL-60 tumoral line around 6 to 10 times lower than those for 8-MOP and 5-MOP (reference drugs), respectively. Finally, application of Iso-contribution Zone Analysis (IZA) provides structural interpretation of the biological activity predicted with this QSAR.

Indexed as

Drug DesignMarkov ChainsComputer SimulationHumansModels, StatisticalOrganic ChemicalsQuantitative Structure-Activity RelationshipTumor Cells, CulturedOrganic Chemicals

Identifiers

PMID13680309
OpenAlexW2008489796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.